Additional file 4: of Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol

A. Prevost (3463448); Aisla Bosworth (6957542); Alison Wright (5454416); Andrew Cope (28317); Andrew Filer (23434); Andrew Ăstor (6957584); Arthur Pratt (3491927); Benjamin Fisher (1816900); Caroline Murphy (3440597); Christopher Buckley (8722); Clare Jacklin (6957563); Coziana Ciurtin (5200694); Dharshene Shivapatham (6957575); Dirkjan Schaardenburg (6957569); Heidi Lempp (3449756); Hill Gaston (6957557); Iain McInnes (2063845); Ian Bruce (43961); Joana Vasconcelos (3463439); Joanna Kelly (3440594); John Isaacs (840151); Karim Raza (23437); Maria-Antonietta DâAgostino (6957581); Mariam Al-Laith (6957527); Marianna Jasenecova (6957533); Paul Emery (8528); Pauline Ho (3053385); Peter Taylor (622122); Sonya Abraham (3602366); Thomas Huizinga (6957560)

journal article text

Additional file 4: of Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol

Abstract

SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013 Checklist: Recommended items to address in a clinical trial protocol and related documents. (DOCX 54 kb

Similar works

Full text

Available Versions

The Francis Crick Institute

oai:figshare.com:article/88748...

Last time updated on 06/04/2020